Cantor cautiously welcomes MYL’s FDA success as EPS upside; Cowen applauds CTMX’s Probody technology.
Gilead Sciences, Inc. (NASDAQ:GILD) announced detailed 48-week results from a Phase 3 study (Study 1878) evaluating the efficacy and safety of switching virologically suppressed …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares are diving nearly 15% in Wednesday’s trading session, following the news that competitor Mylan N.V.
Mylan N.V.
Take a gander at bullish Q2 plays in biotech from one of the richest men in the business.
Valeant’s comeback progresses with new notes offering; RedHill ups the risk ante in favor of time/money.
Cesca Therapeutics Inc (NASDAQ:KOOL) announced today it has received Notice of Allowance for U.S.
It’s a very rewarding trading day for shareholders of Celsion Corporation (NASDAQ:CLSN) with shares up over 130%, making the stock Wall Street’s bull …
Bausch + Lomb, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), announced the introduction of Biotrue® ONEday for Astigmatism daily disposable contact lenses in 20 …
The hedge fund guru’s Q2 moves added ECYT gains to his pocket while saving him greater losses in VRX.
